Highlights from the American Medical Society for Sports Medicine position statement on responsible use of regenerative medicine and orthobiologics in sports medicine
Br J Sports Med
.
2022 Feb;56(3):121-122.
doi: 10.1136/bjsports-2021-104887.
Epub 2021 Oct 31.
Authors
Shane A Shapiro
1
,
Jonathan T Finnoff
2
3
,
Tariq M Awan
4
,
Joanne P Borg-Stein
5
,
Kimberly G Harmon
6
,
Daniel C Herman
7
,
Gerard Malanga
8
9
,
Zubin Master
10
,
Kenneth Mautner
11
Affiliations
1
Department of Orthopedic Surgery, Mayo Clinic, Jacksonville, Florida, USA shapiro.shane@mayo.edu.
2
Physical Medicine and Rehabilitation, Mayo Clinic, Rochester, Minnesota, USA.
3
United States Olympic and Paralympic Committee, Colorado Springs, Colorado, USA.
4
Family Medicine and Sports Medicine, AdventHealth, Orlando, Florida, USA.
5
Department of Physical Medicine and Rehabilitation, Harvard Medical School, Boston, Massachusetts, USA.
6
Family Medicine, University of Washington School of Medicine, Seattle, Washington, USA.
7
Department of Physical Medicine and Rehabilitation, University of California at Davis, Sacramento, California, USA.
8
Department of Physical Medicine and Rehabilitation, Rutgers New Jersey Medical School, Newark, New Jersey, USA.
9
NJ Regenerative Insttitue, Cedar Knolls, New Jersey, USA.
10
Biomedical Ethics Research Program and Center for Regenerative Medicine, Mayo Clinic, Rochester, Minnesota, USA.
11
Department of Rehabilitation Medicine, Emory University School of Medicine, Atlanta, Georgia, USA.
PMID:
34719428
DOI:
10.1136/bjsports-2021-104887
No abstract available
Keywords:
cellular; consensus; ethics; osteoarthritis; platelet-rich plasma.
Publication types
Editorial
MeSH terms
Humans
Regenerative Medicine*
Societies, Medical
Sports Medicine*
United States